CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have No Effect on the Anti-Platelet Action of Clopidogrel

被引：0
|
作者：
El-Halabi, Mustapha [1 ]
Malli, Ahmad [1 ]
Mansour, Nabil [1 ]
Ghaith, Ola [1 ]
Saab, Rayan [1 ]
Mahfouz, Rami [1 ]
Alam, Samir [1 ]
Zgheib, Nathalie [1 ]
Sharara, Ala [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2012年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
120
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] The Effect of CYP2C19 Genetic Polymorphisms and the Concomitant Use of Rabeprazole or Esomeprazole on the Anti-Platelet Action of Clopidogrel
    Sharara, Ala
    Malli, Ahmad
    El-Halabi, Mustapha
    Mansour, Nabil
    Ghaith, Ola
    Harb, Rawda
    Mahfouz, Rami
    Hamoui, Omar
    Alam, Samir
    Zgheib, Nathalie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S37 - S38
  • [2] CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have no Effect on the Antiplatelet Action of Clopidogrel
    El-Halabi, Mustapha M.
    Zgheib, Nathalie
    Mansour, Nabil M.
    Malli, Ahmad
    Ghaith, Ola A.
    Mahfouz, Rami
    Alam, Samir
    Sharara, Ala I.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (01) : 41 - 49
  • [3] EFFECT OF VONOPRAZAN ON THE ANTI-PLATELET FUNCTION OF CLOPIDOGREL OR PRASUGREL IN RELATION TO CYP2C19 GENOTYPE
    Kagami, Takuma
    Yamade, Mihoko
    Ichikawa, Hitomi
    Uotani, Takahiro
    Sahara, Shu
    Hamaya, Yasushi
    Iwaizumi, Moriya
    Osawa, Satoshi
    Sugimoto, Ken
    Miyajima, Hiroaki
    Furuta, Takahisa
    GASTROENTEROLOGY, 2017, 152 (05) : S150 - S151
  • [4] The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
    Alkattan, Abdullah
    Almutairi, Yousef
    Alsalameen, Eman
    Alkhalifah, Ahmed
    Alghanim, Fatimah
    INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (01) : 85 - 87
  • [5] The CYP2C19 gene polymorphism and anti-platelet effect in patients with CHD who treated with PPIs
    Yu, Lianying
    Sha, Weihong
    Wang, Qiyi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 316 - 316
  • [6] Study on the effect of CYP2C19 genetic polymorphism and plasma concentration on clopidogrel resistance
    Wu, Hui
    Chen, Xinli
    Ding, Yongli
    Deng, Yanglin
    Ma, Ruilan
    Chen, Xinyuan
    Li, Xuesong
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (05) : 1685 - 1691
  • [7] A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism
    Hunfeld, N. G.
    Touw, D. J.
    Mathot, R. A.
    van Schaik, R. H.
    Kuipers, E. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 810 - 818
  • [8] CYP2C19*2 polymorphism and clopidogrel resistance
    Joob, Beuy
    Wiwanitkit, Viroj
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (04): : 505 - 505
  • [9] Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes
    Furuta, Takahisa
    Iwaki, Takayuki
    Umemura, Kazuo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (03) : 383 - 392
  • [10] EFFECT OF DIFFERENT PROTON PUMP INHIBITORS ON THE ANTI-PLATELET FUNCTION OF CLOPIDOGREL IN RELATION TO CYP2C19 GENOTYPE STATUS.
    Furuta, T.
    Iwaki, T.
    Umemura, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S43 - S43
12345